JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib. [PDF]
Ceccardi A +17 more
europepmc +1 more source
Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study. [PDF]
Bento L +38 more
europepmc +1 more source
[2018-2024 Cancer Trends in Pathology of a Hospital in Eastern Mexico]. [PDF]
González-Zago A +5 more
europepmc +1 more source
Linfoma multicêntrico em felino doméstico: Relato de caso
Luan de Oliveira +4 more
semanticscholar +1 more source
Linfoma do Manto - Análise retrospectiva da casuística e resultados do serviço de hematologia do Hospital de Santo António nos últimos 8 anos [PDF]
João Pedro de Almeida Moreira Pinto
core
Progression of Myocardial 18F-FDG Uptake in a Patient with Cardiotoxicity. [PDF]
Berenguer DRF +5 more
europepmc +1 more source
Mismatch Between Preclinical Cardio-Oncology and Clinical Oncology Research. [PDF]
Cagnazzo R +6 more
europepmc +1 more source
Sobrevivencia de ratones mediante administración del opioide delta SNC80: modelo de linfoma murino L5178Y-R [PDF]
Caballero Hernández, Diana Elia +4 more
core
Clinical, histopathological, and immunohistochemical characteristics of patients with sicca syndrome with a focus score ≥ 1 in the minor salivary gland biopsy [PDF]
Lamos-Duarte AF +12 more
europepmc +1 more source

